Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Kidney International|March 31, 2006
Effect of fluvastatin on apolipoprotein-defined lipoprotein subclasses in patients with chronic renal insufficiencyP Alaupovic, P-O Attman, C Knight-Gibson, et al.
The American Journal of Cardiology|June 1, 1995
Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatmentsD M Lane, P Alaupovic, C Knight-Gibson, et al.
Mineral and Electrolyte Metabolism|February 22, 2000
Apolipoprotein C-III, hypertriglyceridemia and triglyceride-rich lipoproteins in uremiaJ B Moberly, P O Attman, O Samuelsson, et al.
Journal of the American Society of Nephrology : JASN|August 11, 1998
Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiencyO Samuelsson, P O Attman, C Knight-Gibson, et al.
Biochimica Et Biophysica Acta|June 5, 1992
Isolation and partial characterization of lipoprotein A-II (LP-A-II) particles of human plasmaE D Bekaert, P Alaupovic, C Knight-Gibson, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 18, 2000
Dyslipidemia in peritoneal dialysis--relation to dialytic variablesA C Johansson, O Samuelsson, P O Attman, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiencyO Samuelsson, P O Attman, C Knight-Gibson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 1, 1996
Plasma levels of lipoprotein (a) do not predict progression of human chronic renal failureO Samuelsson, P O Attman, C Knight-Gibson, et al.
Nephron|January 1, 1997
Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal diseaseO Samuelsson, P O Attman, C Knight-Gibson, et al.
Journal of Lipid Research|January 11, 1991
Isolation and characterization of an apoA-II-containing lipoprotein (LP-A-II:B complex) from plasma very low density lipoproteins of patients with Tangier disease and type V hyperlipoproteinemiaP Alaupovic, C Knight-Gibson, C S Wang, et al.
Pageof 3